Experienced in Heart Attack

Mikhail I. Voevoda

The Siberian Branch, 
Novosibirsk, NVS, RU 
Experienced in Heart Attack
The Siberian Branch, 
Novosibirsk, NVS, RU 
OverviewLocationsClinical Research

Overview

Mikhail Voevoda practices in Novosibirsk, Russian Federation. Mr. Voevoda is rated as an Experienced expert by MediFind in the treatment of Heart Attack. His top areas of expertise are Maturity Onset Diabetes of the Young, Atherosclerosis, High Cholesterol, and Diffuse Large B-Cell Lymphoma (DLBCL).

His clinical research consists of co-authoring 136 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 10 articles in the study of Heart Attack.

Gender
Male

Locations

The Siberian Branch, Novosibirsk, NVS, Russian Federation
Other Locations
Siberian Branch, Novosibirsk, NVS, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3

136 Total Publications

Morphological Features of the Myocardium in db/db Mice with Genetically Determined Leptin Resistance and Glucose Metabolism Disorders after Systematic Administration of Recombinant Apolipoprotein A-I.
Morphological Features of the Myocardium in db/db Mice with Genetically Determined Leptin Resistance and Glucose Metabolism Disorders after Systematic Administration of Recombinant Apolipoprotein A-I.
Journal: Bulletin of experimental biology and medicine
Published: March 10, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Voevoda's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile